Carlyle Group Inc. PHAT Holdings History

Number of Shares
3.50 Mil
Current Holdings Value*
$21.92 Mil
% of Portfolio
0.58%
Total Estimate Gain
$1.10 Mil
% of Total Estimate Gain
3.41%

Carlyle Group Inc.'s Phathom Pharmaceuticals Inc Holding Summary

As of 2025-03-31, Carlyle Group Inc. held 3.50 Mil shares of Phathom Pharmaceuticals Inc(PHAT), totaling $21.92 Mil. This investment constitutes 0.58% of their stock portfolio, and Carlyle Group Inc. now holds 5.01% of the outstanding Phathom Pharmaceuticals Inc(PHAT) stock.

The initial trade took place in 2023Q1. And since then Carlyle Group Inc. has made 2 purchases of PHAT, at an average price of $9.21, for a total of 3.50 Mil shares. Based on historical transaction data and PHAT's current price of $9.53, Carlyle Group Inc.'s estimated gain on his PHAT holdings is $1.10 Mil, reflecting a 3.41% gain to date.

Carlyle Group Inc. PHAT ($9.53) Holding Chart

Carlyle Group Inc. PHAT ($9.53) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1